Insights and challenges in tuberculosis vaccine development

Insights and challenges in tuberculosis vaccine development

Tuberculosis kills more people than any other pathogen and the need for a universally effective vaccine has never been greater. An effective vaccine will be a key tool in achieving the targets set by WHO in the End TB Strategy. Tuberculosis vaccine development is difficult and slow. Substantial prog...

Detaylı Bibliyografya
Yazar:	McShane, H
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2019

Benzer Materyaller

Tuberculosis vaccines: Progress and challenges
Yazar:: Checkley, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Vaccines for tuberculosis
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2013)

Challenges in developing a controlled human tuberculosis challenge model
Yazar:: Jackson, S, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Vaccine strategies against tuberculosis
Yazar:: H McShane
Baskı/Yayın Bilgisi: (2009-03-01)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2011)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
Yazar:: Vermaak, S, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
Yazar:: Stylianou, E, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
Yazar:: Fletcher, H, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Tuberculosis vaccines: progress and challenges.
Yazar:: Checkley, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2023)

Why don’t we have an effective tuberculosis vaccine yet?
Yazar:: Davenne, T, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
Yazar:: Villarreal-Ramos, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Clinical testing of tuberculosis vaccine candidates
Yazar:: Hatherill, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
Yazar:: Tanner, R, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
Yazar:: Griffiths, K, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Developing an improved vaccine against tuberculosis.
Yazar:: Mcshane, H
Baskı/Yayın Bilgisi: (2004)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
Yazar:: Dockrell, HM, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Human and Bovine Tuberculosis
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2016)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
Yazar:: Morrison, H, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Progress and challenges in TB vaccine development
Yazar:: Voss, G, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Vaccination against tuberculosis: how can we better BCG?
Yazar:: Pitt, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Vaccination against tuberculosis: How can we better BCG?
Yazar:: Pitt, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
Yazar:: Hazel M. Dockrell, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Vaccine strategies against tuberculosis.
Yazar:: Mcshane, H
Baskı/Yayın Bilgisi: (2009)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
Yazar:: Minassian, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.
Yazar:: Sander, C, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Exploring the ethics of tuberculosis human challenge models
Yazar:: Rohrig, A, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Controlled human infection models: is it really feasible to give people tuberculosis?
Yazar:: McShane, H
Baskı/Yayın Bilgisi: (2020)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
Yazar:: Hopkins, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Local pulmonary immunological biomarkers in tuberculosis
Yazar:: Morrison, H, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
Yazar:: Hazel Morrison, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
Yazar:: Mcshane, H, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Tuberculosis vaccines in clinical trials.
Yazar:: Rowland, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Tuberculosis vaccines: present and future.
Yazar:: Minassian, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle.
Yazar:: Villarreal-Ramos, B, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
Yazar:: Villarreal-Ramos, B, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

TB vaccines in clinical development
Yazar:: Ginsberg, AM, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Statistical challenges in the development and evaluation of marker-based clinical tests
Yazar:: McShane Lisa M
Baskı/Yayın Bilgisi: (2012-05-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
Yazar:: Griffiths, K, ve diğerleri
Baskı/Yayın Bilgisi: (2011)